Financial & Legal Considerations for Life Sciences Partnerships

Innovative Partnership & Management Opportunities
Product, Portfolio & Market Development

December 10-11, 2019

Philadelphia, PA

Event Overview

Creating innovative life sciences, pharma and biotech mergers and partnership opportunities has never been more critical to organizational growth.  As product offerings grow, the industry is being impacted by rapidly changing market conditions, pricing considerations, and legislative updates. Don’t miss the opportunity to learn from and network with leaders in pharma, life sciences, and M&A.

Through a comprehensive agenda comprised of case studies and expert panels, you’ll gain timely insights into U.S. Anti-Trust Trends, what CFIUS could Mean for your M&A endeavor, due diligence best practices, and raising series funding. In addition, meet and network with essential industry stakeholders across both sides of the aisle, in a collaborative setting. Don’t miss this unique opportunity to gain best practices for developing your business strategy, while considering regulations.  

Sheraton Philadelphia University City Hotel


3549 Chestnut St.
Philadelphia, PA 19104

Hotel Website

Special Event Rate
Book Now

Top 5 Reasons to Attend

  1. Gain lessons learned from recent acquisition, merger and partnerships
  2. Learn what transpires for buyers and sellers before the deal is made and how to ensure you are prepared
  3. Understand how elements of effective due diligence to ensure the best deal
  4. Acquire tools to structure the deal while considering recent U.S. Anti-Trust developments
  5. Enjoy numerous opportunities to network with pharma leaders and M&A experts 

Attendee Profile

This conference is designed for biotech and pharma senior-level executives and legal counsel responsible for:

  • Business Development
  • Commercial and Corporate Strategy
  • Digital Strategy
  • Divestitures
  • Due Diligence
  • Finance
  • General Counsel/Corporate Counsel
  • Intellectual Property and Patent Counsel
  • Investor Relations
  • Legal
  • Licensing
  • Lifecycle Management
  • Mergers & Acquisitions
  • Medical Strategy
  • Patient Strategy
  • Portfolio Strategy
  • Product Strategy
  • Research and Development
  • Regulatory Affairs
  • Search and Evaluation
  • Scientific Assessment
  • Analyst

Tuesday, December 10th, 2019 | Day 1

8:00 AM - 9:00 AM

Registration & Continental Breakfast

9:00 AM - 9:30 AM

Chairperson’s Day 1 Opening Remarks

9:30 AM - 10:15 AM

OPENING ADDRESS: Emerging Pharma, Biotech & Med Device Investment Trends & Opportunities in 2020 & Beyond

Join with other executives to decipher what the financial transactions and life sciences corporate landscape can predict for 2020 & beyond.

Topics include:

  • Review the billion-dollar M&A & financial deals of 2019
  • Explore analysts’ predictions for future trends
  • Discuss techniques to capitalize on future trends

10:15 AM - 10:30 AM

Morning Networking & Refreshment Break

10:30 AM - 11:15 AM

Managing Pipeline Opportunity & Risk in a Mid-size Pharmaceutical Company

Learn how sharing risk and financial burdens with external partners strengthens your partnerships.

This session will:

  • Teach important financial and legal strategies from five recent diverse transactions
  • Uncover how to share financial risks and burdens with external partners
  • Discuss the financial and legal strengths and challenges encountered in several recent partnerships
  • Share techniques to strengthen financial transactions

Ivan Kugener, MD MBA MSc - Vice President, Head of Global Portfolio Management - Global Strategic Excellence
EMD Serono

11:15 AM - 12:00 PM

CFIUS and What it Could Mean for your M&A, Partnership and Investment Transactions

12:00 PM - 1:00 PM

Networking Lunch

1:00 PM - 1:45 PM

Planning & Raising Series Funding

Laying the foundation for achieving financing is a difficult task but calculated-fundraising efforts are critical.

Participants in this session will:

  • Discover funding sources
  • Learn best practices for successful fundraising
  • Establish actionable plans to achieve funding goals

Vipula Tailor, CEO

1:45 PM - 2:30 PM

CASE STUDY: Why a Strategic Partnership Can Be Better than a Merger or an Acquisition

What are the criteria for strategic or financial partnerships? When are these better than a merger or an acquisition?

Participants will:

  • Learn how to identify synergies between companies
  • Discuss companies sharing new product development costs & distribution for a win-win partnership
  • Examine the formation & outcomes of current strategic partnerships in pharma & biotech

2:30 PM - 3:00 PM

Afternoon Networking & Refreshment Break

3:00 PM - 3:45 PM

Acquiring? Want to be acquired? Choosing the Right Financial Advisor or Investment Banker

Listen to expert advice on the obvious & the sublime to guide managers in hiring the right partner for their unique situations.

Discussion will cover:

  • What criteria should be considered when evaluating outside financial counsel?
  • How does this change for the “being acquired” versus the “acquirer?”

3:45 PM - 4:15 PM

Open Forum Q&A

4:15 PM - 4:30 PM

Day 1 closing remarks

Wednesday, December 11th, 2019 | Day 2

8:00 AM - 9:00 AM

Networking Breakfast & Registration

9:00 AM - 9:30 AM

Chairperson’s Day 1 Recap & Day 2 Introduction

9:30 AM - 10:15 AM

KEYNOTE ADDRESS: Strategic Exits - Start from the Beginning!

Learn key factors to enhance successful outcomes & avoid deal-ending scenarios.

Focus on creating value in financial partnerships from day 1 thru exit & explore:

  • Tools to continuously improve the value of a business
  • Steps business owners can take to increase their purchase price
  • Exit strategy options at various company life stages
  • Pitfalls to avoid for successful strategic exits

David Sheppard - Managing Director

Florence Joffroy-BlackCEO

10:15 AM - 10:30 AM

Morning Networking & Refreshment Break

10:30 AM - 11:15 AM

CASE STUDY: Acquirers Share Their M&A Experiences

M&A veterans will share their insights into financial and legal trends, market drivers and criteria for acquisition opportunities.

Among the questions they will answer are:

  • When is the right time to strike a deal?
  • Sell or acquire – which road to take?
  • How do buyers define value?
  • What criteria and market drivers indicate a good opportunity?

Michael Hong - Chief Investment Officer and Portfolio Manager

Jason Colgate - Managing Director of Private Equity Acquisitions

11:15 AM - 12:00 PM

CASE STUDY: How Smaller Drug Companies Bring New Innovations from Trial to Market

This presentation will disrupt how you think about bringing new drugs to market.

Attendees will:

  • Learn how to pull, instead of push, your drug to market
  • Discuss insights into international options to enhance an organization, making it more attractive for mergers or partnerships
  • Examine steps involved in navigating regulatory bodies on a global level
  • Share criteria used to determine whether a company is a good financial partner

Bill Abajian - Chief Operating Officer, Restructuring, and Turn-Arounds
Eastgate Biotech

12:00 PM - 1:00 PM

Networking Lunch

1:00 PM - 1:45 PM

Intellectual Property Strategies that Close Transactions - Navigating the Legal Process & Attracting Capital

Life science companies can use intellectual property (IP) to make their businesses attractive for strategic partners or buyers.

In this program, participants will:

  • Explore basic questions related to IP development
  • Identify the questions life science companies must answer to attract capital
  • Share techniques companies can use to streamline the due diligence. process
  • Provide legal and financial insights into how to protect revenue streams

Gregory Grissett - Intellectual Property Lawyer and Chair Intellectual Property Group

1:45 PM - 2:30 PM

Mitigating Risk with Due Diligence Best Practices

Due diligence can make or break any deal.

This presentation will cover:

  • Importance of transparency
  • Best practices
  • Opportunities to seize the moment
  • Strategies to mitigate challenges and risks

Rahul Khara - Senior Director, Compliance and Commercial Counsel

2:30 PM - 3:00 PM

Afternoon Networking & Refreshment Break

3:00 PM - 3:45 PM

CASE STUDIES: IPO, Venture Capital, & Legal Alternatives for Product, Portfolio & Market Development

Attend this session to gain a greater understanding of the financing options available to sellers and buyers.

These case studies will:

  • Explore the effects of financial alternatives on transaction types
  • Explain how pharma and biotech companies have executed strategies for successful market share development
  • Uncover techniques to boost therapeutic share development
  • Look at transactions from both the buy and sell side

Bill Abajian - Chief Operating Officer, Restructuring, and Turn-Arounds

Michael Hong - Chief Investment Officer and Portfolio Manager

Jason Colgate - Managing Director of Private Equity Acquisitions

3:45 PM - 4:15 PM

Open Forum Q&A

4:15 PM - 4:30 PM

Day 2 closing remarks





Speakers & Faculty

David Sheppard

David Sheppard

Managing Director
Medworld Advisors

Bill Abajian

Bill Abajian

COO, Restructuring, and Turn-Arounds
Eastgate Biotech

Florence Joffroy-Black

Florence Joffroy-Black

Medworld Advisors

Gregory Grissett

Gregory Grissett

Intellectual Property Lawyer and Chair Intellectual Property Group
Offit Kurman, P.A.

Rahul Khara

Rahul Khara

Senior Director, Compliance and Commercial Counsel
Acceleron Pharma

Vipula Tailor

Vipula Tailor

Azure 8

Jason Colgate

Jason Colgate

Managing Director of Private Equity Acquisitions
Eli Global

Michael Hong

Michael Hong

Chief Investment Officer and Portfolio Manager
Strategic Growth Investments




After 9/12/19



Register at Event


Register 2 Attendees, Get 1 Complimentary Registration*!

Interested in sending groups of 7 or more? Contact us directly for pricing.

* Standard Pricing Only



Are you a vendor, consultancy, or solutions provider? Our attendees want to hear what you have to offer their organization. We can customize sponsorship packages tailored to your marketing needs.

Please contact Michael Goldberg at (561) 221-6202 or